The Lancet Respiratory Medicine Published Study Shows Ensartinib Holds Promise as a New Treatment Option for ...

PALM BEACH GARDENS, Fla.--(BUSINESS WIRE)--Xcovery Holdings, Inc., an oncology-focused biopharmaceutical company, today announced that ensartinib, the company's lead drug candidate, demonstrated efficacy and safety in patients with"...